The LDL:HDL ratio is a standard atherogenicity summary: a lipid change is favorable if it lowers the ratio, harmful if it raises it. Here HDL-C rose (~1.23 to 1.47 mmol/L; O-97) while LDL-C did not change (O-98), so the ratio numerator was flat and the denominator rose — arithmetically the ratio falls or holds, i.e., moves in the non-atherogenic direction. The load-bearing subtlety is the absorber stratification: a common worry is that dietary-cholesterol “hyper-absorbers” would show an LDL rise that offsets the HDL benefit; the observation that the LDL:HDL ratio was maintained similarly in both hyper- and hypo-absorbers (O-98) blocks that escape route, showing the neutral-to-favorable pattern is not an artifact of averaging over a harmed subgroup and a benefited subgroup. Hence the data support a neutral-to-favorable net lipid classification for whole eggs on this background (H-40). Caveat carried into H-40, not this argument: the CRD background independently raises HDL and lowers TG, and n is small, so the classification is about direction/sign, not effect size in a general population.
Validity verdict (step 6)
status: approved, checked. Reconstruction: explicit premise is that the LDL:HDL ratio is a valid atherogenicity summary of a lipid change (favorable if it falls, harmful if it rises); the step is: HDL up + LDL flat ⇒ ratio falls-or-holds ⇒ moves in the non-atherogenic direction; and holding within BOTH absorber strata ⇒ the pattern is not an averaging artifact masking a harmed subgroup ⇒ neutral-to-favorable, not atherogenic. Conditional on the ratio-as-metric premise the arithmetic and the subgroup logic trace cleanly. Note the “neutral-to-favorable” range maps exactly onto the argument’s own “falls or holds” hedge (holds = neutral, falls = favorable), so the conclusion is not an overclaim relative to O-98’s “ratio did not change” — it does not need to be corrected down to “neutral” only. Undercutting-defeater probe: the strongest defeater — that LDL:HDL omits ApoB/LDL particle number and HDL-raising is not reliably cardioprotective (CETP/niacin RCT failures), so a preserved ratio could still be atherogenic — attacks the premise that the ratio validly summarizes atherogenicity, and the conclusion is explicitly scoped to the “lipid effect / lipid classification,” not to clinical outcome. Within that scope the premise is granted and the step holds. checked: elementary arithmetic plus stratum logic, author-blind.